T2 Biosystems Regains Compliance With Nasdaq's Market Value Of Listed Securities Requirement
Portfolio Pulse from Benzinga Newsdesk
T2 Biosystems, Inc. (NASDAQ:TTOO) has regained compliance with the NASDAQ's market value of listed securities (MVLS) requirement. The company was previously notified of non-compliance due to failure to maintain a MVLS of at least $35 million for 30 consecutive business days. To regain compliance, T2 Biosystems maintained a MVLS of at least $35 million for 10 consecutive trading days. The company must still demonstrate compliance with the Bid Price Rule by November 20, 2023.
August 09, 2023 | 12:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
T2 Biosystems has regained compliance with NASDAQ's MVLS requirement, which could potentially boost investor confidence in the company. However, the company still needs to demonstrate compliance with the Bid Price Rule by November 20, 2023.
Regaining compliance with NASDAQ's MVLS requirement is a positive sign for T2 Biosystems as it indicates the company's market value has improved. This could potentially boost investor confidence in the company. However, the company's need to demonstrate compliance with the Bid Price Rule by November 20, 2023, could introduce some uncertainty.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100